RavenQuest BioMed (CNSX:RQB) Best Conditioned Growing Technology Worldwide

By |

Watch

Midas Letter

The Digital Businesss Channel for Cannabis, Crypto and Technology Stocks.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

RavenQuest BioMed Inc (CNSX:RQB) (OTCMKTS:RVVQF) (FRA:1IT) CEO George Robinson joins Midas Letter to discuss the company’s recent approval from Health Canada to verify the proficiency and capability of the company’s orbital garden technology. The RavenQuest Orbital Garden allows for production of large quantities of cannabis in smaller areas by maximizing the productivity of grow space and lighting. After the evidence provided by Health Canada, the CEO is now ready to say RavenQuest is “best conditioned from a growing technology out of anyone, worldwide.” The novel growing technology is more efficient than traditional flat-table growing operations allowing for a decrease in the cost of power, nutrients and labour. Since the news, RavenQuest BioMed have been enjoying a surge of inquiries for possible technology uptake to global partners. Listen to the full interview to learn more about the company’s technological engineering feats and RavenQuest’s profitability expectations and future targets.

Transcript

Narrator: RavenQuest Biomed is a diversified cannabis company with divisions focused upon cannabis production, management services and consulting, and specialized research and development.

RavenQuest maintains a research partnership with McGill University focused on cultivar strain recognition, plant stabilization, and yield maximization of the cannabis plant.

The company focuses on partnerships with Indigenous communities.

RavenQuest Biomed trades on the CSE under the symbol RQB.

James West: I’m joined in studio now by George Robinson. George, welcome back.

George Robinson: Good to be back.

James West: George, there’s been a lot of discussion in the broad sort of social universe about the viability of orbital gardens and how effective they’re going to be at growing good cannabis. Recently, Health Canada paid you a visit and gave you a very clean bill of health. Give me an update on what that visit was all about.

George Robinson: Yeah, it was really great to have them there. It’s the first time they’ve been onsite, so they did a full two-day inspection. They looked right from the very beginning processes to the very end process of our building, but spent a lot of time with the gardens. They spent a lot of time looking at our first harvest results, called the Certificate of Analysis; they found out that we had zero microbial notices on any of them, which they said this is one of the first they’ve ever seen at that.

So really, what we have right now is, we have a proven technology that’s been growing and growing to the data sheets, which means it’s performing to the exact requirements of that cultivar that’s laid out, and we’ve proven the technology is growing to the amounts that we wanted, and Health Canada has given us the nod to say, What you’re doing is very, very good.

James West: Okay, then, so it seems like orbital gardening might be even superior to conventional hydroponic gardening?

George Robinson: I think I’m ready to say that now. You know, sometimes I’ve always been a little bit cautious; I don’t want to promote. But now that we have the approval of Health Canada, we know what our cost structure is looking at with the crops that are going through, I can say very, very specifically, we can take a run at any flat-table environment, any greenhouse, cost-wise and quality-wise.

I think we’re best conditioned from a growing technology out of anyone, worldwide.

James West: Wow, great. On that note, Aphria reported profitability in their fourth quarter, but they reported expenses of over $2.30 all-in growing costs per gram. How much does it cost you to grow a gram of marijuana?

George Robinson: We’re much less. You know, we’re probably half of them on the cash cost to grow the cannabis, so that’s right through to the drying process, and we’re easily half of their price on the all-in, meaning right to the packaging, price. We’re getting the efficiencies out of the gardens from the cost of power, the cost of nutrients. We only use 21 people in our facility to grow 7,000 kilograms, so we’ve taken the four major components of cost and we’ve nailed those down and brought them down significantly.

And our gardens are proving what we’ve said for the last three years: it will be the technology, the innovation, to move forward.

James West: And so, is the uptake in the use of orbital gardening from your partners likely to proceed, or rather, accelerate, as a result of these tests?

George Robinson: I’m going to tell you something: all of our partners are really excited. They had no questions before, but to get the approval of Health Canada to say that they were onsite, they’ve seen it, now all of a sudden, the phone starts ringing even more so. And the calls are coming from Europe, which we’re extremely excited about, and our local partners here, too, are calling. And new people are calling. They’ve started to realize that Health Canada was on site, and they go, Okay: All the concerns are gone. The gardens are working, and they’re delivering as promised.

James West: So, do you think, can this statement be considered factual if we were to say that orbital gardening is, in fact, the most efficient way to grow cannabis?

George Robinson: I would say categorically, yes. There is nothing that’s even close to it right now that I’ve seen. Remember, and I’ve been in, probably now, over 50 facilities around the country. I’ve been in European facilities, I’ve taken a look at issues that are in there. Remember, with the zero microbial count off our COAs, that means we have no issues relative to mildew or any other type of bacteria and/or funguses that’s there. It’s completely eliminated in our growing style, and we get that because we can control the environment and the canopy so tightly in that drum.

So I can say, categorically, we’ll take on anyone, any day.

James West: Sure. So in terms of growing it in a drum like that, I just like to learn a little bit more about it every time I hear about it. I’m curious as to, so, the air movement inside the drum must be present such that there is absolutely zero sort of microbial or pathogenic reproductive activity able to establish. So, how do you make the air movement in there consistent across the whole canopy as far as it exists in an orbital environment?

George Robinson: Yeah, so the gardens themselves are really great technology, but really, what it comes down to is the complete building design and the climate-control design. Where most people are getting away with about 300 feet per minute of airflow through a room, our design has 800-plus feet of airflow through the room. So that’s the first thing.

Then at the canopy level, we have under-flow of air that comes up underneath the canopy as it’s rotating, and we have fans across the top of the canopy. So there is no dead space, there’s no dead air; all plants are moving.

But remember what’s most important about microclimates, as you referred to, is we don’t have all the massive fan leaf that stops that air flow through there. The plant doesn’t need to generate it in that drum. So the plant leaf, the big foliar leaf, is not there, so we don’t have those restrictions. So every plant has its own movement around it, and they’re not overlapping, and they don’t touch.

So if you can do that, you can eliminate that with airflow across it, and we’ve been able to design it engineering to that canopy.

James West: Wow. So it sounds like you’re really on track for profitability, and everything that you’ve said you’re going to do, you’ve actually achieved.

George Robinson: Yeah, and you know, some of the numbers that we’ve been out there promoting, we now know that they’re real, and we’re going to hit them, and we’re going to target them. And the fact that we now know our costing structure, and we’ve got some people who are absolutely passionate about growing in these environments, including Dr. Simerjit Kaur, and her background, double PhD background; we’re very excited that we’ve hit everything that we wanted to do. And it’s been three years in the making now to see and to get to this point.       

James West: Right. Okay, George, let’s leave it there for now. We’ll come back to you again soon. Thanks for joining me today.

George Robinson: And thanks for having me.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

Free Newsletter,
Priceless Content.

Be the First to Hear from Midas Letter on Investment News, Videos, and More.